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ABSTRACT: Modeling approaches such as quantitative structure−activity relationships (QSARs) use molecular descriptors to
predict the bioavailable properties of a compound in biota. However, these models have mainly been derived based on empirical
data for lipophilic neutral compounds and may not predict the uptake of ionizable compounds. The majority of pharmaceuticals
are ionizable, and freshwaters can have a range of pH values that affect speciation. In this study, we assessed the uptake of 10
pharmaceuticals (acetazolamide, beclomethasone, carbamazepine, diclofenac, gemfibrozil, ibuprofen, ketoprofen, norethin-
drone, propranolol, and warfarin) with differing modes of action and physicochemical properties (pKa, log S, log D, log Kow,
molecular weight (MW), and polar surface area (PSA)) by an in vitro primary fish gill cell culture system (FIGCS) for 24 h in
artificial freshwater. Principal component analysis (PCA) and partial least-squares (PLS) regression was used to determine the
molecular descriptors that influence the uptake rates. Ionizable drugs were taken up by FIGCS; a strong positive correlation was
observed between log S and the uptake rate, and a negative correlation was observed between pKa, log D, and MW and the
uptake rate. This approach shows that models can be derived on the basis of the physicochemical properties of pharmaceuticals
and the use of an in vitro gill system to predict the uptake of other compounds. There is a need for a robust and validated model
for gill uptake that could be used in a tiered risk assessment to prioritize compounds for experimental testing.
■ INTRODUCTION
Pharmaceuticals are biologically active molecules that have
been detected in surface waters at nanogram to microgram per
liter concentrations1 and are widely reported in aquatic fauna.2
The impacts associated with pharmaceutical exposure of
aquatic organisms is unclear, and knowledge is necessary to
inform regulatory authorities and the pharmaceutical industry
of compounds that may pose a risk.3
As part of a chemical risk assessment, it is necessary to
determine the likelihood of bioaccumulation. A bioconcentra-
tion factor (BCF) is a measure which includes uptake (k1) and
elimination rates (k2) and internal steady state concentra-
tion.4,5 However, the uptake process, along with metabolism,
represents the largest factors of uncertainty in fish
bioaccumulation models,6,7 and BCF values for individual
compounds derived from in vivo studies can vary substan-
tially.8 Consequently, a novel approach to evaluate the
bioavailability properties of a chemical has been proposed
which utilizes nonguideline methodologies in a tiered risk
assessment.8 In this approach, in silico or in vitro data may be
used in the lower tiers to assess a chemical’s bioavailability; if
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there is enough information to classify bioaccumulation
potential, then a decision can be made as to whether further
BCF studies are required.8
Many mechanistic assessments of contaminant uptake are
based on in silico models, such as quantitative structure−
activity relationships (QSARs), that have largely been derived
from data for lipophilic neutral compounds that passively
diffuse across lipid membranes and undergo little to no
metabolism.6 QSARs can include linear-based estimations or
more recently, machine learning applications such as neural
networks and tree-based learning to predict organic chemical
bioconcentration.9 However, an estimated 77.5% of pharma-
ceuticals are ionizable.10 Thus, the applicability of the QSAR
models developed on other contaminant classes (i.e., neutral
hydrophobic contaminants) may be limited leading to
inaccurate estimation of the accumulation of pharmaceuticals.
For compounds that are ionizable, the acid−base dissociation
constant (pKa) describes the dissociation of the drug at a given
pH and influences solubility, lipophilicity, permeability, and
protein binding.11 In the aquatic environment, surface water
pH will determine chemical speciation, and this is predicted to
have an influence on bioavailability.12 The typical pH values of
environmental water range between 6 and 9,12 although fish
can be found in bodies of water that are extremely acidic (pH
3)13 and highly alkaline (pH 10.5).14 The effects of pH on the
toxicity12 and uptake/elimination of ionizable compounds in
fish have been demonstrated.15−17 Recently, Bittner et al.18
demonstrated the impact of pH (5.5−8.6) on the uptake and
toxicity of beta-blocker pharmaceuticals in zebrafish larvae;
where the skin is likely to be the significant route of uptake.
Karlsson et al.19 examined the effects of water and sediment
pH (5.5−8.5 pH) on the uptake of three pharmaceuticals with
a range of pKa (4.01−9.62 pKa) in the freshwater oligochaete
Lumbriculus variegatus.
There is a desire to develop in vitro models that replace or
supplement current animal experimental procedures20 in
accordance with the replacement, reduction, and refinement
(3Rs) principle.21 This is also reflected in European legislature
which states that non-animal alternative approaches should be
used in place of animal procedures wherever possible. A fish
gill cell culture system (FIGCS) was developed using primary
fish cells which has shown promise as an alternative system for
whole fish chemical uptake studies.22 FIGCS maintains many
of the characteristics of the in vivo epithelium, including the
presence of multiple cell types associated with transport of ions
across the gills and the ability to tolerate freshwater−water
application to the apical surface. The in vitro data obtained
from FIGCS experiments has the potential to be an important
component of the lower tier in a tiered testing system8 as the
gills are a primary route of uptake in fish.22It has recently been
used to investigate the absorption of seven pharmaceuticals
with a similar pKa of 8.1 to 9.6 across the gill.
23
There is a paucity in fish pharmaceutical uptake and BCF
values because the tests to derive these use a large number of
organisms, are time-consuming, and are expensive to conduct.
In this study, we assessed the uptake of 10 pharmaceuticals by
an in vitro fish gill model with differing physiochemical
properties and there were three aims. The first aim was to
assess the uptake of ionizable pharmaceuticals with this fish gill
epithelium. The second aim was to demonstrate how an in
vitro epithelial model can be used to evaluate the propensity of
a drug to enter a fish from the water and how this information
could become part of a tiered risk assessment approach.8,24
Lipsinki et al.25 proposed that the molecular properties
(molecular weight, hydrogen bond donors and acceptors,
and log Kow) of a chemical can be used as a screening tool to
determine the likelihood of absorption across a membrane; our
third aim was to extend this concept and use the
pharmaceutical molecular descriptors and partial least-squares
(PLS) regression analysis to model uptake rate and identify
those descriptors which influence gill uptake. We were able to
show that solubility, pKa, octanol−water distribution coef-
ficient at pH 7.4, and molecular weight are the most important
descriptors that drive epithelial drug uptake rates.
■ MATERIALS AND METHODS
Fish Gill Cell Culture System (FIGCS). Juvenile rainbow
trout (Oncorhynchus mykiss) were obtained from a local trout
farm and housed in dechlorinated−aerated, London city tap
water ([Na+] = 0.53 mM, [Ca2+] = 0.92 mM, [Mg2+] = 0.14
mM, [K+] = 0.066 mM, and [NH4
+ ] = 0.027 mM). The
temperature was maintained at 14 °C with a 14 h light:10 h
dark cycle, and fish were fed a 1% (w/v) ration of trout pellets
daily.
Primary fish gill cell culture inserts were prepared in
companion wells and maintained according to protocols
described in Schnell et al.22 The transepithelial resistance
(TER) was monitored daily using an epithelial tissue
voltohmmeter (EVOMX) with STX-2 chopsticks (World
Precision Instruments). A TER value of above 3000 Ω cm−2
was used as criteria for the presence of a tight epithelium, as
previously determined using 14C-mannitol as a paracellular
permeability marker.23
Pharmaceuticals’ Exposures and Cell Viability Assay.
Analytical grade pharmaceuticals (purity ≥97%) from differing
classes of action with differing chemical properties (Table 1)
were purchased from Sigma-Aldrich and included acetazola-
mide (CAS: 59-66-5), beclomethasone (CAS: 4419-39-0),
Table 1. Pharmaceutical Molecular Descriptors
pKa log S molecular wt (g mol
−1) log D log Kow PSA (Å
2) % ionization at pH 7.6
acetazolamide 7.20 −2.36 222.24 0.23 3.48 115.04 71.5
beclomethasone 13.85 −5.4 408.92 4.16 3.49 106.97 0
carbamazepine 15.96 −3.2 236.27 2.28 2.28 46.33 0
diclofenac 4.00 −4.8 296.15 1.22 1.9 52.16 100
gemfibrozil 4.42 −4 250.33 1.40 4.77 46.53 99.9
ibuprofen 4.91 −3.5 206.28 0.29 2.48 40.10 99.8
ketoprofen 4.45 −4.1 254.28 0.06 0.97 54.37 99.9
norethindrone 17.59 −4.7 298.40 2.98 3.15 37.30 0
propranolol 9.42 −3.5 259.34 1.29 3.09 41.49 98.5
warfarin 5.08 −3.8 308.32 0.16 0.85 63.60 99.7
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carbamazepine (CAS: 298-46-4), diclofenac sodium salt (CAS:
15307-79-6), gemfibrozil (CAS: 25812-30-0), ibuprofen
sodium salt (CAS: 31121-93-4), ketoprofen (CAS: 22071-
15-4), norethindrone-19 (CAS: 68-22-4), propranolol hydro-
chloride (CAS: 318-98-9), and warfarin (CAS: 81-81-2).
Pharmaceutical stocks were prepared at a concentration of 1
mg mL−1 in methanol or ethanol and stored at −80 °C.
Following the formation of a tight epithelium, inserts were
prepared for exposure by washing with phosphate buffered
saline. The apical freshwater (AFW) used for apical exposure
was prepared according to the OECD203 test guidelines
26 (2
mM CaCl2, 0.5 mM MgSO4, 0.8 mM NaHCO3, 77.1 μM KCl,
with a measured pH 7.6) with individual pharmaceuticals
added at a concentration of 1 μg mL−1, which is equivalent to
450 nM acetazolamide, 245 nM beclomethasone, 423 nM
carbamazepine, 338 nM diclofenac, 399 nM gemfibrozil, 485
nM ibuprofen, 393 nM ketoprofen, 355 nM norethindrone,
386 nM propranolol, and 324 nM warfarin. To expose the
cells, 1.5 mL of exposure water was added to the apical
compartment and 2 mL of L15 media with 5% FBS was added
to the basal compartment. The inserts and the 1.5 mL
exposure water samples (T0) were incubated at 18 °C in the
dark for 24 h. In the case of the T0 samples, this was to assess if
the compounds remained stable over the 24 h exposure period
at 18 °C in the absence of cells. The T0 and the 1.5 mL apical
compartment water samples after a 24 h exposure (T24) were
collected and stored at −80 °C for further analysis.
Measurements were made on four inserts derived from two
to three biological replicates, with each biological replicate
comprising of cells harvested from two fish.
To consider the adhesion of the compounds to the
companion well and insert membrane during the 24 h of
exposure, a cell-free experiment was performed. To assess
pharmaceutical toxicity, single seeded primary gill cells were
grown in T75 flasks to 80% confluence and then trypsinized
and transferred to the 96-well plates at a density of 1 × 105
cells well−1. Twenty-four hours postseeding in the 96-well
plates, cells were exposed to pharmaceuticals at 1 μg mL−1 in
L15 with 5% FBS for 24 h, after which a MTT viability assay 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
was performed following methods adapted from Riss et al.27
The pH stability of the AFW with 1 μg mL−1 of compound was
measured with and without cells and found to be stable over a
24 h period.
HPLC Analysis. For HPLC analysis, individual T0 or T24
samples were pooled into three separate mixtures: mix A
included beclomethasone, ibuprofen, and warfarin, mix B
included carbamazepine, diclofenac, gemfibrozil, ketoprofen,
and norethindrone, and mix C included acetazolamide and
propranolol for solid phase extraction (SPE) with Oasis HLB
cartridges (200 mg sorbent, 6 cm3). Cartridges were initially
conditioned with 6 mL of methanol (HPLC grade) followed
by 6 mL of water (HPLC grade) and then loaded with pooled
sample mix A, B, or C. Cartridges were washed with 4 mL of
water, dried under vacuum pressure, and eluted with 6 ml of
methanol or stored at −80 °C for later elution. The samples
were then dried under nitrogen at 45 °C for 80 min (Biotage
TurboVap), reconstituted in 500 μL of 90:10 (v/v) water/
acetonitrile, and vortexed for 2 min before transfer to amber
HPLC vials for analysis.
Liquid chromatography was performed on an Agilent 1260
Infinity series LC system using a Waters Sunfire C18 column
(100 Å, 3.5 μm, 2.1 mm × 150 mm) at a flow rate of 0.2 mL
min−1 and an injection volume of 20 μL. Mobile phases A and
B consisted of HPLC grade water and HPLC grade
acetonitrile, respectively, with initial running conditions of
10% phase B at a column temperature of 40 °C. The gradient
elution was as follows: linear ramp with phase B increased to
80% at 12 min, held for 13 min, and then returned to initial
conditions at 28 min. The total run time was 40 min including
a 12 min re-equilibration period. An Agilent 1290 Infinity
Diode Array Detector was used for the detection of diclofenac
and warfarin at 214 nm; carbamazepine, ibuprofen, and
gemfibrozil at 220 nm; beclomethasone and propranolol at
230 nm; norethindrone at 254 nm; ketoprofen at 263 nm; and
acetazolamide at 273 nm.
Method performance was assessed by matrix-matched
calibration curves generated for the AFW. Method linearity
(5 concentrations, n = 3) was determined from 0.5 to 2.5 μg
mL−1, and signal-to-noise ratios of 3:1 and 10:1 of low
concentration spiked samples were used to determine the LOD
and LOQ, respectively (n = 6). Precision was determined using
spiked samples at 1 μg mL−1 (n = 6), and accuracy was
determined using spiked samples and values from method
linearity (n = 6). Recovery was assessed by comparing spiked
samples (pre-extraction) to postextract spiked samples at a
concentration of 0.5, 1, or 2 μg mL−1 (n = 3).
Estimation of Gill Uptake Rates. Primary gill cell culture
pharmaceutical uptake was calculated based on the loss of
compound from the apical compartment corrected for the
amount that adhered to the polystyrene plastic of the
companion wells and inserts without cells over 24 h (eq 1)
= − − − ] ×
− −
T T T T t
Uptake rate (nmol cm h )
( ) ( ) /( cm )
2 1
0 24 0
p
24
p 2
(1)
where T0 and T24 represent the moles (nmol) of drug
present in the apical compartment in the presence of cells at 0
and 24 h, respectively, and T0
p and T24
p represent the moles of
drug present in the apical compartment in the absence of cells
at 0 and 24 h, respectively; t = time of the flux measurement
(24 h), and cm2 represents the surface area of the epithelium
(0.9 cm2). Sorption controls (inserts and exposure media only)
were setup to account for any losses of compound through
volatilization, sorption to plastics, and any other degradative
processes. Insert controls showed that these processes were
negligible, and therefore, in the presence of cells, the
disappearance of a compound is related to the uptake of the
compound into the gill epithelium and its transfer across into
the basolateral layer over 24 h.
Statistics and Modeling Approaches. A one-way
ANOVA followed by a Tukey’s post hoc test was performed
to compare the uptake rates of each compound using
GraphPad Prism 6.0. Modeling approaches used six molecular
descriptors (Table 1) including the acid dissociation constant
(pKa), the octanol−water distribution coefficient at pH 7.4
(log D), the octanol−water partition coefficient (log Kow),
polar surface area (PSA), and molecular mass (Mw). The two
descriptors log Kow and log D are both measures of
hydrophobicity, but log D takes into account both neutral
and ionizable species at a given pH whereas log Kow only takes
into account the neutral fraction. Principal component analysis
(PCA) and partial least-squares (PLS) regression were
performed using the R statistical computing language, R
version 3.4.3 (freely available at https://www.r-project.org/).
All scripts were written with RStudio (freely available at
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https://www.rstudio.com/); packages used for PCA and PLS
analyses were stats and plsdepot, respectively. The full data set
used in modeling, latent variable scores, loadings, weights, and
cross-validations of models are given in Figure S3 and Tables
S4−S7). For cross-validation of the PLS model, a leave-one-
out approach was used.
■ RESULTS
Cell viability was assessed by MTT assay and none of the
pharmaceuticals at a concentration of 1 μg mL−1 showed signs
of cytotoxicity (Figure S1); HPLC method performance
assessment is provided in Tables S1 and S2.
Pharmaceutical adhesion to the companion wells over 24 h
was between 0.7 and 5% (data not shown) and was taken into
consideration when uptake rates were calculated. Acetazola-
mide uptake (0.125 ± 0.032 nmol cm−2 h−1) was significantly
greater than those of beclomethasone, carbamazepine,
diclofenac, and norethindrone (beclomethasone, 0.021 ±
0.015 nmol cm−2 h−1; carbamazepine, 0.022 ± 0.004 nmol
cm−2 h−1; norethindrone, 0.024 ± 0.003 nmol cm−2 h−1;
diclofenac, 0.027 ± 0.003 nmol cm−2 h−1) (Figure 1). The
other ionizable drugs, except for diclofenac, showed higher, but
not significantly higher, uptake rates (ibuprofen, 0.072 ± 0.013
nmol cm−2 h−1; gemfibrozil, 0.075 ± 0.007 nmol cm−2 h−1;
ketoprofen, 0.061 ± 0.006 nmol cm−2 h−1; propranolol, 0.095
± 0.026 nmol cm−2 h−1; and warfarin, 0.070 ± 0.012 nmol
cm−2 h−1) compared to the neutral drugs beclomethasone,
carbamazepine, and norethindrone (Figure 1 and Figure S2).
Modeling of the molecular descriptors was performed using
PCA analysis to identify compound similarity (Figure 2). The
first two principal components explained a cumulative variance
of 69% (PC1 = 48%, PC2 = 21%) in the descriptor space. The
score plot indicates that there were no apparent outliers in the
data set. Clustering of compounds was minimal but was
expected with the low number of cases available for modeling
(n = 10). The largest variation in the descriptor space was
observed for the compound beclomethasone (Figure 2). The
variance of this case can be explained in terms of the loadings,
where this compound was the largest (MW = 408.92) and
most hydrophobic (log D = 4.16) of all the compounds that
were tested. From the descriptor loadings, log S and MW were
negatively correlated with each other. The loadings for the first
latent variable also showed that log D (0.567), MW (0.505),
log S (−0.444), and pKa (0.407) were more important
variables than log Kow (0.201) or PSA (0.146).
PLS was implemented to interpret molecular descriptors
that influence gill uptake rates of pharmaceuticals and enable a
predictive modeling approach with
= ‐ + − ‐ × + ‐ ×
+ − ‐ × + ‐ ×
+ − ‐ × + ‐ ×
− −
K S
D K
Uptake rate (nmol cm h )
1.23E 01 ( 1.59E 03 p ) (1.53E 02 log )
( 7.26E 03 log ) (9.15E 03 log )
( 9.48E 05 MW) (3.83E 04 PSA)
2 1
a
ow
(2)
The adjusted correlation coefficient (R2adj) and the cross-
validated R2 (Q2) of the PLS regression model were 0.7863
and 0.5397, respectively. No cases were observed as outliers in
the PLS model determined by the Hotelling’s T2 95%
confidence ellipse (data not shown). On the basis of the
cumulative Q2 statistic (see Figure S4), the optimal number of
latent variables for the PLS model was two. The loadings plot
(Figure 3a) indicated that log S was positively correlated with
gill uptake whereas log D, pKa, and MW were negatively
correlated with gill uptake. The log Kow and PSA descriptors
were relatively less important in modeling gill uptake when
compared with the previously mentioned descriptors. The use
of PLS to predict gill uptake showed good performance with
the mean absolute error of 0.01 ± 0.01 nmol cm−2 h−1 (MAE
± SD) for all the compounds tested. Larger inaccuracies in the
predictions were observed for the four compounds: carbama-
zepine (122%), diclofenac (61%), norethindrone (35%), and
propranolol (32%) (Figure 3b,c).
Figure 1. Pharmaceutical uptake rate into the fish gill cell culture
system. Values represent average of four inserts derived from 2 to 3
biological replicate, with each biological replicate comprising of cells
from 2 fish. Bars with differing letters are significantly different from
each other when compared via a one-way ANOVA followed by a
Tukey’s posthoc test; p < 0.05.
Figure 2. PCA biplot showing the first two principal component
(PC1 and PC2) loadings and scores for each molecular descriptor and
case, respectively. Scores are indicated on the first axes (left and
bottom, black); loadings are indicated by the second axes (right and
top, red). A, acetazolamide; B, beclomethasone; C, carbamazepine; D,
diclofenac; G, gemfibrozil; I, ibuprofen; K, ketoprofen; N,
norethindrone; P, propranolol; W, warfarin.
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■ DISCUSSION
The uptake rate of 10 pharmaceuticals by a fish primary gill cell
culture system was assessed. From our data set, we were able to
demonstrate that a PLS regression model based on the drug
molecular descriptors could be developed for pharmaceutical
uptake rate by this epithelium, with log S, pKa, log D, and MW
found to be the most important descriptors that drive epithelial
drug uptake rates.
The uptake rates of the compounds from the apical
compartment reflect the apparent epithelial permeability
(Papp) of the compound by the FIGCS cells. The Papp can be
expressed as an equation (eq 3) and takes into consideration
four factors: partitioning in the aqueous boundary layer (PABL,
ABL), adhesion to filter insert (Pf), and transcellular (trans) or
paracellular (para) transfer (Ptrans, Ppara).
28 The aqueous
boundary layer is assumed to have a distinct boundary with
the bulk water adjacent to both sides of the membrane.29
= + +
+P P P P P
1 1 1 1
app ABL f trans para (3)
Two of the four factors can be discounted due to the nature
of the system. First, adhesion to plastic (Pf) and inserts was
taken into consideration when calculating the uptake rate.
Second, a previous study conducted using the paracellular
marker 14C-mannitol determined that at TER values above
3000 Ω cm2, the FIGCS were relatively impermeable to the
marker and indicated that transport was via transcellular
routes;23 all compounds in the current study had a greater
molecular weight than mannitol and thus paracellular transfer
(Ppara) was negligible. Thus, the uptake rates reflect
partitioning in the ABL (PABL)and uptake into cells and across
the basolateral membrane (Ptrans) into the basolateral compart-
ment in addition to any potentially metabolized compound
efflux from the gill cells back into apical compartment.
All uptake studies were conducted in AFW, and under these
conditions acetazolamide (71.5%), diclofenac (100.0%),
gemfibrozil (99.9%), ibuprofen (99.8%), ketoprofen (99.9%),
propranolol (98.5%), and warfarin (99.7%) are all predicted to
be ionized (% ionization is indicated in parentheses), whereas
beclomethasone, carbamazepine, and norethindrone are not
ionized. All ionizable drugs, except diclofenac, showed higher
permeation into the primary gill cell epithelium when
compared to the neutral drugs (Figure 1). The observation
that ionizable drugs are capable of permeating the gill
epithelium corroborates a previous study in FIGCS concerning
the uptake of a set of pharmaceuticals with pKa between 8.1
and 9.6,23 and a number of studies suggest that ionizable
compounds can be taken up by the fish gill.15,16,18,19,23,30,31
The uptake of nine weakly acidic chlorinated phenols by
rainbow trout did not vary between pH 6.3 and 8.4 despite the
proportion of the compounds that ranged in ionization from 1
to 99%;15 the accumulation of the weak basic diphenhydr-
amine (pKa 9.1) at 10 μg L
−1 reached a steady state in fathead
minnow at pH 7.73 and 8.63 after ∼24 h, and only at pH 6.87,
was accumulation greatly reduced31 and ionizable surfactant,32
perfluoroakyl acids,33 and phenols and carboxylic acids34 were
observed to cross the gills of fish. However, membrane
permeation may be an order of magnitude less than that for the
neutral form.30 Erickson et al.16 developed a mechanistic
model of ionized organic chemical uptake at the fish gill which
expanded on an original model for un-ionized chemical
uptake.35,36 This new model included a factor that takes into
account the ability of the fish to alter the pH adjacent to the
apical membrane thus generating a microclimate that differs
from the bulk water.37 These changes in pH at the gill surface
helped to explain the uptake of diphenylamine31 and the
chlorinated phenols.15,16 However, in the current study, uptake
of the acidic and basic pharmaceuticals showed similar uptake
rates, and if uptake is solely due to the neutral form of the
drug, then the pH of the culture epithelial microclimate would
have to be in the region of pH 3 to ensure that the weakly
acidic drugs (pKa 4−5.08) were un-ionized. It is also unlikely
that uptake is solely due to the ionized form because the basic
drugs show similar uptake rates (Figure 1 and reference 23). In
contrast to the other ionizable compounds, diclofenac is the
only drug that exhibited a relatively lower uptake rate. It is
unclear why this may be; but of the drugs used in the current
study, the structure of diclofenac is more complex, containing
both an amine and carboxylic acid group, and lacks
Figure 3. PLS regression analysis showing (A) loadings of the first
two latent variables for molecular descriptors (independent variables)
and uptake rate (dependent variable), (B) predicted versus observed
gill uptake rates using PLS regression model, and (C) raw residuals of
predicted uptake rates.
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conformational flexibility38 which may influence transport by
the gill epithelium.
The PLS modeling approach showed that all descriptors
here have an influence on the uptake rate, but more of the
explained variance was correlated to the log S, log D, pKa, and
MW descriptors. The regression model (eq 2) showed a good
potential to predict uptake rates in the FIGCS system at the
tested concentration and water chemistry (r2 = 0.786).
Modeling is an important aspect in understanding the fate of
pharmaceuticals in the aquatic environment, and these
approaches are complementary to in vitro systems for the
replacement of animal testing. Comparison to in vivo fish
uptake rates would be useful; however, there are a limited
number of studies reporting these values. We have collated the
‘steady state’ plasma concentrations for 9 of the 10
pharmaceuticals in Table S8; but note that the complexity
and variation in pH, exposure, species, size, and temperature
make a direct comparison to our data difficult. Furthermore,
these studies do not allow us to derive uptake rates and
therefore are not suitable for comparison with our data set.
Predicted K1, LC50, and BCF values can be derived from
QSAR models for fish (Table S8). However, a poor correlation
was observed between the predicted K1, LC50, and BCF values
and our in vitro pharmaceutical uptake rates (Table S8),
emphasizing the need for alternative models for these
compounds. To fully validate the model, a much larger
number of compounds would be needed. A robust and
validated model for gill uptake could then be used as a
prescreen to prioritize compounds for experimental testing in a
tiered approach.8 In this scenario, if a compound is predicted
to not be bioavailable in in vitro studies and other information
from lower tier screens support this observation, then further
BCF testing in living fish may not be required.8,24
The pharmaceutical uptake rate was most strongly positively
correlated to log S (Figure 2b) suggesting that this
physiochemical property facilitates access of the pharmaceut-
icals to the cells and uptake. The ABL in multiwell plates is
between 1000 and 2000 μm and forms a significant diffusional
barrier39 whereby the concentration in bulk solution exceeds
that located at the membrane surface. Increased solubility aids
permeability across the ABL29 allowing for greater interaction
with the membrane.40 Carbamazepine was expected to have a
higher uptake based on solubility as well as being neutral and
hydrophobic, but influx rates were low, and carbamazepine had
the largest prediction inaccuracy in the PLS regression model.
The reason for this is uncertain. Carbamazepine has a low BCF
value in adult zebrafish (BCFss of 1.41 ± 7.13 L kg
−1), but this
is likely associated with greater biotransformation capacity and
clearance rather than a significant reduction in uptake when
compared to other pharmaceutical and personal care products
tested.17 Whether the gills actively excrete carbamazepine back
into the apical water compartment remains to be determined.
Carbamazepine’s mode of action is promiscuous, and it
interacts with different types of receptors and channels.41
However, the main targets are voltage-gated Na+ channels
located on the surface of the cells41 where carbamazepine acts
as a competitive inhibitor by allosteric inhibition.42 A
possibility is that in our system, the drug adheres to and
interacts with the surface and related channels but does not
permeate into the cell.
A negative correlation of uptake rates with log D was
observed. The gill membrane consists of a range of
phospholipids (e.g., phosphatidylethanoilamines and phospha-
tidylcholine) with differing properties capable of forming
electrostatic and hydrogen bonds with charged molecules. It
has been shown that ionized drugs can partition into artificial
lipid membranes greater than predictions based on log Kow,44
and there is a positive relationship between the dipole potential
in the region between the aqueous phase and the interior
membrane bilayer allowing permeation of ionized compounds
in these synthetic membranes.24,45,46 This phenomenon gave
rise to the pH-piston hypothesis to explain sorption of ionized
drugs into artificial vesicles consisting of dioleylphosphatidyl-
choline, due to electrostatic interactions with acidic and basic
drugs,45 and may explain how the ionized compounds are able
to cross the membrane.
The PLS regression also indicated that the uptake rates were
negatively correlated with MW. MW is known to play a distinct
role in cellular uptake of solutes and has been used successfully
to model permeability of both neutral and charged molecules;
this is in addition to being a component of Lipinski’s rule of
five in drug discovery.43,47,48 The log Kow and PSA accounted
for some of the variance in the regression but to a much lesser
extent than the other molecular descriptors.
The role of transport proteins in ionizable drug uptake is
axiomatic,49−51 but the extent of the role that transport
proteins play in drug uptake is debated. Kell and colleagues
proposed that uptake is almost solely due to transport
proteins,52 though this has been strongly questioned.53,54 In
our current study, all flux rates were measured at
concentrations that far exceed environmental concentrations
and it is likely that carrier mediated transport processes were
saturated. Here, we are measuring both the passive and
facilitated uptakes, with passive uptake being dominant and
entry likely via electrostatic interactions with the phospholipid
membrane of the fish gill.24 But several organic, anion, cation,
or zwitterion transporters are present at the gill, e.g., slco1d1,55
OATP,56 and slc15a2,57 and their ability to facilitate drug
uptake from the water requires further understanding. An
alternative explanation for the uptake of charged molecules is
transportation as ion-pairs:58 a property that has been utilized
to assist in developing drug penetration for a number of
epithelia, such as the ocular epithelium59 and the skin,60 but
has not been considered for fish gill epithelia. Natural water
contains numerous potential counterions, and the fish excretes
ions and other charged molecules from the gill that could form
ion-pairs with charged drugs.
■ ENVIRONMENTAL IMPLICATIONS
The current study shows that the FIGCS can be used to assess
drug uptake by fish gills from the water in accordance with
previous studies.23 It also shows that ionizable drugs are able to
cross the gill epithelium, but further work is required to
ascertain the significance of the gill microclimate at the apical
membrane with respect to ion pairing, electrostatic interactions
(between the ionized pharmaceutical and the membrane
phospholipids), and transport proteins on ionizable compound
transport. A PLS regression model based on the physicochem-
ical properties of the drug was used to predict uptake rate (the
model accounted for 78% of the explained variance) where log
S, pKa, log D, and MW were significant drivers. To fully
validate the model, a much larger number of compounds
would be needed; however, this approach shows that modeling
can be used to understand the uptake of pharmaceuticals by an
in vitro epithelial system that could replace whole animals in
bioaccumulation studies. There is a need for a robust and
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validated model for gill uptake that could then be used as a
prescreen to prioritize compounds for experimental testing in a
tiered risk assessment8 where compounds that do not cross the
gill epithelia may not need further costly and time-consuming
animal testing.
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Cezard, T.; Day, J. J. High levels of interspecific gene flow in an
endemic cichlid fish adaptive radiation from an extreme lake
environment. Mol. Ecol. 2015, 24, 3421−3440.
(15) Erickson, R. J.; McKim, J. M.; Lien, G. J.; Hoffman, A. D.;
Batterman, S. L. Uptake and elimination of ionizable organic
chemicals at fish gills: I. Model formulation, parameterization, and
behavior. Environ. Toxicol. Chem. 2006, 25, 1512−1521.
(16) Erickson, R. J.; McKim, J. M.; Lien, G. J.; Hoffman, A. D.;
Betterman, S. L. Uptake and elimination of ionisable organic
chemicals at fish gills: II. Observed and predicted effects of pH,
alkalinity, and chemical properties. Environ. Toxicol. Chem. 2006, 25,
1522−1532.
(17) Chen, F.; Gong, Z.; Kelly, B. C. Bioaccumulation behavior of
pharmaceuticals and personal care products in adult zebrafish (Danio
rerio): Influence of physical-chemical properties and biotransforma-
tion. Environ. Sci. Technol. 2017, 51, 11085−11095.
(18) Bittner, L.; Teixido, E.; Seiwert, B.; Escher, B. I.; Klüver, N.
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